From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.
Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.
Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
A three-part VJSession featuring GU cancer experts Elizabeth Plimack, Thomas Powles and Rana McKay who discuss the latest advances and hot topics in bladder and kidney cancer from ASCO 2021.